India and NICE to collaborate on 'evidence-informed' healthcare
This article was originally published in Scrip
India's health and family welfare ministry and the National Institute for Health and Clinical Excellence (NICE) in England and Wales plan to work together to provide a framework for strategic and technical co-operation between the two countries on "evidence informed" healthcare policy and practice.
You may also be interested in...
Years after a scathing Indian parliamentary report flagged concerns around regulatory lapses for drug approvals, an expert panel has endorsed the continued marketing of ambrisentan and everolimus in the country. But dronedarone, also featured in the report, is no longer sold by Sanofi in India.
Tecentriq cleared for extensive-stage small cell lung cancer in India but pricing remains a key constraining factor. Patient assistance schemes help but such novel therapies still unaffordable to a vast majority.